Observational studyBMC infectious diseases2026
Hematological and biochemical markers for predicting severity in COVID-19 patients.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Haematological and Biochemical Parameters of COVID-19 Patients Hospitalised at Selected Central Hospitals in Malawi: A Retrospective Study.Health science reports · 2026Article
- Integrated Inflammatory, Thrombo-Inflammatory, Redox and Soluble IFNAR2 Profiling During Hospitalization for COVID-19: An Exploratory Observational Cohort Study.Journal of clinical medicine · 2026Article
- Inflammatory Biomarkers and Clinical Outcomes in Hospitalized Hemodialysis Patients with COVID-19: A Retrospective Observational Study.Diagnostics (Basel, Switzerland) · 2026Article
- Correlation of serum ferritin, D dimer and CRP levels with disease severity among hospitalized patients in India.Bioinformation · 2026Article
- Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe early identification of patients at risk of severe coronavirus disease 2019 (COVID-19) is a clinical priority. This study aimed to evaluate hematological and inflammatory biomarkers between mild and severe cases of COVID-19 in an Indian cohort.
methodsA retrospective observational study was conducted on 240 RT-PCR-confirmed COVID-19 patients admitted to Shree Krishna Hospital, Gujarat, India. Patients were classified as severe (n = 170) or non-severe (n = 70) based on clinical criteria. Levels of interleukin-6 (IL-6), ferritin, D-dimer, C-reactive protein (CRP), lactate dehydrogenase (LDH), and hematological parameters were analyzed upon hospital admission. Data were analyzed using SPSS, version 24.0. The Shapiro-Wilk test assessed normality. The Mann-Whitney U test was used for non-normally distributed variables in group comparisons, while the independent samples t-test was used for normally distributed variables. Diagnostic performance was evaluated via Receiver Operating Characteristic (ROC) curve analysis, and associations with severe disease were examined using logistic regression.
resultsPatients with severe disease were significantly older (median 61.5 vs. 47 years, p < 0.001). Severe illness was demonstrated significant association with elevated inflammatory markers (IL-6, ferritin, LDH, CRP, D-dimer; all p < 0.001) and hematological dysregulation, notably neutrophilia, lymphocytopenia, and an elevated neutrophil-to-lymphocyte ratio (NLR) (all p < 0.001). ROC analysis identified LDH (AUC = 0.76), ferritin (AUC = 0.74), and NLR (AUC = 0.73) as the best discriminators, with optimal cut-offs of 319 U/L, 255 µg/L, and 4.3, respectively. In multivariate analysis adjusted for age and other biomarkers, only older age (adjusted OR: 1.03 per year; 95% CI: 1.00–1.05; p = 0.008) and elevated ferritin (adjusted OR: 1.44; 95% CI: 1.03–2.01; p = 0.03) maintained a statistically significant independent association with severe disease. The significant univariate associations for IL-6, LDH, and CRP were attenuated in the adjusted model.
conclusionAdmission levels of IL-6, NLR, ferritin, and LDH showed strong associations with COVID-19 severity and offered good discriminatory value for risk stratification. However, after accounting for key confounders, older age and hyperferritinemia were the factors most robustly and independently associated with severe outcomes. These findings underscore the importance of multivariate evaluation to identify core prognostic factors and support the use of accessible biomarkers like ferritin and NLR in triage protocols.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.